ID: ALA3649363

Max Phase: Preclinical

Molecular Formula: C25H34ClN3O7S

Molecular Weight: 556.08

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](NC(=O)[C@@H]1C[C@@H](S(=O)(=O)c2ccc(Cl)cc2C)CN1C(=O)OC(C)(C)C)C(=O)C(=O)NC1CC1

Standard InChI:  InChI=1S/C25H34ClN3O7S/c1-6-18(21(30)23(32)27-16-8-9-16)28-22(31)19-12-17(13-29(19)24(33)36-25(3,4)5)37(34,35)20-10-7-15(26)11-14(20)2/h7,10-11,16-19H,6,8-9,12-13H2,1-5H3,(H,27,32)(H,28,31)/t17-,18+,19+/m1/s1

Standard InChI Key:  GYPJWYCZYZSAOS-QYZOEREBSA-N

Associated Targets(Human)

CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSB Tchem Cathepsin B (3822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 556.08Molecular Weight (Monoisotopic): 555.1806AlogP: 2.54#Rotatable Bonds: 8
Polar Surface Area: 138.95Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.74CX Basic pKa: CX LogP: 2.95CX LogD: 2.95
Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.47Np Likeness Score: -1.12

References

1.  (2014)  Pyrrolidine derivatives, 

Source

Source(1):